(Total Views: 289)
Posted On: 04/08/2022 1:50:56 PM
Post# of 56

$CHRS News Article - Coherus and Junshi Biosciences Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting https://marketwirenews.com/news-releases/cohe...20748.html


My Twitter: WhyteStocks